CMB International
招银国际
elsewhere's corpus does not cover CMB International directly — no article in the bundle is actually about the firm itself. The references that appear are limited to deal co-investor lists and cap-table mentions in coverage of portfolio companies.
From those passing citations, CMB International (招银国际 / 招银国际资本) shows up as an active venture and growth investor across Chinese biotech and tech. It led the Series A of protein-tech platform Yinjia Bio in early 2023 , and has followed in rounds for synthetic biology player Enhe Biotechnology (2021) , AI-driven pharma METiS Pharmaceuticals (2022) , 3D cell-manufacturing platform CytoNiche (2025) , and AI company Zhuiyi (2021) . It also backed materials firm Tianjin Nankai Hecheng Technology in its 2024 Series B . The mix suggests a focus on hard-tech and life-science bets, often alongside top-tier VCs such as Sequoia China, 5Y Capital, and Gaorong Ventures.
AI-generated — may contain errors, please verify.
Coverage
3D Cell Manufacturing Platform Huaxin Biotech Closes Series B+ Round to Accelerate Cell Therapy Commercialization for Global Clients
Ushering in the 2.0 era of cell-based industrialization.
Nankai Hecheng Completes 200 Million Yuan Series B Round | BlueRun Ventures Family
Accelerating Toward a Trillion-Yuan Future for the Polypeptide Industry
Year-end good news: CDH Investments has raised 5 billion yuan for logistics investments.
Insurance capital is turning its attention to real estate investments.
Yinjia Biotech Closes Nearly RMB 100 Million Series A Round to Accelerate Buildout of Upstream Core Protein Ingredient Synthetic Biology Platform
Staying true to our mission as "protein craftsmen."
New Tracks, Interdisciplinary Fields, Down-Market Expansion, Data Infrastructure... Four Companies Raise Nearly 1.2 Billion RMB in Funding | FreeS Family Funding News · Vol 10
Looking forward to working alongside more outstanding founders.
Quantum Computing, 3D Sensor Chip Companies Secure New Funding; New Brands, Robotics, and Healthcare Firms Advance Globally | Rongbao · April
Summer begins, and all things grow.
Huashun Xin'an Closes Hundreds of Millions of RMB in Series C Funding to Build Cyberspace Security Ecosystem
Build a world-class cyberspace mapping engine, and construct the foundational infrastructure for cyberspace security ecosystems.
5Y News | METiS Pharmaceuticals Closes Two Consecutive Rounds Raising $150 Million Total
Become an industry innovation leader.
7 Companies Raised Nearly 1.5 Billion Yuan, 4 Valued Above 1 Billion Yuan | FreeS Family Funding News · September
Every step of growth for an innovative company: from 0 to 1, from 1 to 10, and from 10 to 100
As Fierce as August | 5Y News Monthly
The big news from last month.
5Y News | Synthetic Biology Company Bota Bio Raises Over $100 Million to Accelerate Efficient Design and Scaled Production of Bio-based Products
5Y Capital continues to pay close attention to emerging technologies at the intersection of information science and life sciences.
5Y News | Zhuiyi Technology Secures Strategic Investment of Several Hundred Million RMB
Exploring the commercial boundaries of AI technology.
